PRESS RELEASE published on 03/19/2026 at 18:30, 1 month 19 days ago Oxurion ondertekent een intentieverklaring voor de overname van een internationale CRO. Oxurion NV plant die Übernahme eines Mehrheitsanteils an einer internationalen CRO, um ihr integriertes klinisches Entwicklungsmodell zu stärken Übernahme Oxurion NV Mehrheitsanteil Klinische Entwicklung Internationale CRO
BRIEF published on 03/18/2026 at 18:05, 1 month 20 days ago Oxurion reçoit une notification de transparence d'Atlas Special Opportunities Transparence Financière Pharmaceutique Atlas Special Opportunities Investissements Digitaux Oxurion
BRIEF published on 03/18/2026 at 18:05, 1 month 20 days ago Oxurion Acknowledges Transparency Notification from Atlas Pharmaceuticals Transparency Oxurion Belgian Legislation Atlas Investments
BRIEF published on 03/18/2026 at 18:05, 1 month 20 days ago Oxurion accuse réception de la notification de transparence d'Atlas Transparence Médicaments Oxurion Législation Belge Atlas Investments
BRIEF published on 03/18/2026 at 18:05, 1 month 20 days ago Oxurion receives a transparency notification from Atlas Special Opportunities Pharmaceutical Financial Transparency Atlas Special Opportunities Oxurion Digital Investments
PRESS RELEASE published on 03/18/2026 at 18:00, 1 month 20 days ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV (Euronext Brussel: OXUR) ontvangt transparantiekennisgeving met betrekking tot aandelenbezit en kondigt ambitie aan om Europese farmaceutische onderaannemers te verwerven Transparantiekennisgeving Euronext Brussel Oxurion NV België Farmaceutische Onderaannemers
PRESS RELEASE published on 03/18/2026 at 18:00, 1 month 20 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV received a transparency notification from Atlas Special Opportunities II, LLC indicating a stake increase above the threshold. Oxurion specializes in acquiring pharmaceutical subcontractors Transparency Notification Oxurion NV Belgian Transparency Legislation Atlas Special Opportunities II Pharmaceutical Subcontractors
BRIEF published on 03/16/2026 at 18:05, 1 month 22 days ago Oxurion expands its capital following the conversion of bonds Ordinary Shares Convertible Bonds Capital Increase Atlas Oxurion
BRIEF published on 03/16/2026 at 18:05, 1 month 22 days ago Oxurion élargit son capital suite à la conversion d'obligations Obligations Convertibles Atlas Actions Ordinaires Oxurion Augmentation Capital
BRIEF published on 03/16/2026 at 18:05, 1 month 22 days ago Oxurion Increases Voting Shares Following Conversion Voting Rights Convertible Bonds Capital Increase Atlas Special Opportunities Oxurion
Published on 05/08/2026 at 00:00, 11 minutes ago Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 41 minutes ago Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 22:05, 2 hours 6 minutes ago MicroVision and Avular Collaborate to Advance Autonomous Sensing and Drone Integration for Next-Generation Infrastructure Applications
Published on 05/07/2026 at 22:05, 2 hours 6 minutes ago Innodata Reports Record First Quarter 2026 Results
Published on 05/07/2026 at 23:23, 47 minutes ago H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 57 minutes ago EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 2 hours 6 minutes ago Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 3 hours 29 minutes ago RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 5 hours 25 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/07/2026 at 19:15, 4 hours 56 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 4 hours 56 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 5 hours 5 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 5 hours 5 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 5 hours 11 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
